Latest filing published 04 Jan 2022 for CYTOKINETICS INC, €4,934. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Robert Califf is a declared insider of Cytokinetics Inc (board member), with filings sourced from SEC (Form 4). The record holds 5 filings, for trades running from 12 May 2021 to 3 January 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 4 January 2022, reports a share grant of €4,934 in Cytokinetics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations